Funding Of First Clinical Trial With Disease-Modifying Therapy For Rett Syndrome Announced By IRSF
Links shared publicly online about this topic.
- 1,730total visits
Funding Of First Clinical Trial With Disease-Modifying Therapy For Rett Syndrome Announced By IRSF
Today, the International Rett Syndrome Foundation announced that it will provide $200,000 in 2009 to support a newly proposed clinical trial with a growth-factor based treatment for Rett Syndrome.
View full resource at medicalnewstoday.com
Tags: Autism Spectrum Disorder, Rett Syndrome, Disease and Condition, Clinical Trial
Most Recently Shared on September 22, 2009 at 2:20 pm By:
Funding Of First Clinical Trial With Disease-Modifying Therapy For Rett Syndrome Announced By IRSF: Today, the I.. http://bit.ly/Eph4L
Also Shared By:
Advertisement
MNT Neurology News
@mnt_neurology
Funding Of First Clinical Trial With Disease-Modifying Therapy For Rett Syndrome Announced By IRSF: Today, the I.. http://bit.ly/Eph4L
1 year ago...